Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study

Overview of attention for article published in Frontiers in oncology, October 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 5 public wall posts from 5 users.

Doxycycline and vitamin C appear to work synergistically to inhibit the growth of breast cancer stem cells. —https://www.ncbi.n…

DOXYCYCLINE USES INCLUDE CANCER…

Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer…

Doxycycline and vitamin C appear to work synergistically to inhibit the growth of breast cancer stem cells. —https://www.ncbi.n…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity, including 1 additional Facebook posts.